These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 16627561)
1. APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer. Groskopf J; Aubin SM; Deras IL; Blase A; Bodrug S; Clark C; Brentano S; Mathis J; Pham J; Meyer T; Cass M; Hodge P; Macairan ML; Marks LS; Rittenhouse H Clin Chem; 2006 Jun; 52(6):1089-95. PubMed ID: 16627561 [TBL] [Abstract][Full Text] [Related]
2. PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy. Marks LS; Fradet Y; Deras IL; Blase A; Mathis J; Aubin SM; Cancio AT; Desaulniers M; Ellis WJ; Rittenhouse H; Groskopf J Urology; 2007 Mar; 69(3):532-5. PubMed ID: 17382159 [TBL] [Abstract][Full Text] [Related]
3. The diagnostic value of PCA3 gene-based analysis of urine sediments after digital rectal examination for prostate cancer in a Chinese population. Shen M; Chen W; Yu K; Chen Z; Zhou W; Lin X; Weng Z; Li C; Wu X; Tao Z Exp Mol Pathol; 2011 Feb; 90(1):97-100. PubMed ID: 20970419 [TBL] [Abstract][Full Text] [Related]
4. A multicenter evaluation of the PCA3 molecular urine test: pre-analytical effects, analytical performance, and diagnostic accuracy. Sokoll LJ; Ellis W; Lange P; Noteboom J; Elliott DJ; Deras IL; Blase A; Koo S; Sarno M; Rittenhouse H; Groskopf J; Vessella RL Clin Chim Acta; 2008 Mar; 389(1-2):1-6. PubMed ID: 18061575 [TBL] [Abstract][Full Text] [Related]
5. PCA3 sensitivity and specificity for prostate cancer detection in patients with abnormal PSA and/or suspicious digital rectal examination. First Latin American experience. Ramos CG; Valdevenito R; Vergara I; Anabalon P; Sanchez C; Fulla J Urol Oncol; 2013 Nov; 31(8):1522-6. PubMed ID: 22687565 [TBL] [Abstract][Full Text] [Related]
7. Prostate cancer gene 3 urine assay for prostate cancer in Japanese men undergoing prostate biopsy. Ochiai A; Okihara K; Kamoi K; Iwata T; Kawauchi A; Miki T; Fors Z Int J Urol; 2011 Mar; 18(3):200-5. PubMed ID: 21332814 [TBL] [Abstract][Full Text] [Related]
8. The time-resolved fluorescence-based PCA3 test on urinary sediments after digital rectal examination; a Dutch multicenter validation of the diagnostic performance. van Gils MP; Hessels D; van Hooij O; Jannink SA; Peelen WP; Hanssen SL; Witjes JA; Cornel EB; Karthaus HF; Smits GA; Dijkman GA; Mulders PF; Schalken JA Clin Cancer Res; 2007 Feb; 13(3):939-43. PubMed ID: 17289888 [TBL] [Abstract][Full Text] [Related]
15. PCA3: a molecular urine assay for predicting prostate biopsy outcome. Deras IL; Aubin SM; Blase A; Day JR; Koo S; Partin AW; Ellis WJ; Marks LS; Fradet Y; Rittenhouse H; Groskopf J J Urol; 2008 Apr; 179(4):1587-92. PubMed ID: 18295257 [TBL] [Abstract][Full Text] [Related]
16. Reflex PCA3 messenger ribonucleic acid testing: validation of postbiopsy urine samples and correlation with prostate biopsy findings in ∼2000 patients. Brown JG; Fulmer JR; Romano J; Pownell J; Rigler W; Wirtshafter A; Sarno M; Shappell SB Urology; 2014 Nov; 84(5):1172-80. PubMed ID: 25443926 [TBL] [Abstract][Full Text] [Related]
17. DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer. Hessels D; Klein Gunnewiek JM; van Oort I; Karthaus HF; van Leenders GJ; van Balken B; Kiemeney LA; Witjes JA; Schalken JA Eur Urol; 2003 Jul; 44(1):8-15; discussion 15-6. PubMed ID: 12814669 [TBL] [Abstract][Full Text] [Related]
18. Clinical utility of the prostate cancer gene 3 (PCA3) urine assay in Japanese men undergoing prostate biopsy. Ochiai A; Okihara K; Kamoi K; Oikawa T; Shimazui T; Murayama S; Tomita K; Umekawa T; Uemura H; Miki T BJU Int; 2013 May; 111(6):928-33. PubMed ID: 23331404 [TBL] [Abstract][Full Text] [Related]
19. PCA3 urine mRNA testing for prostate carcinoma: patterns of use by community urologists and assay performance in reference laboratory setting. Shappell SB; Fulmer J; Arguello D; Wright BS; Oppenheimer JR; Putzi MJ Urology; 2009 Feb; 73(2):363-8. PubMed ID: 18995890 [TBL] [Abstract][Full Text] [Related]
20. PCA3 urinary test versus 1H-MRSI and DCEMR in the detection of prostate cancer foci in patients with biochemical alterations. Panebianco V; Sciarra A; De Berardinis E; Busetto GM; Lisi D; Buonocore V; Gentile V; Di Silverio F; Passariello R Anticancer Res; 2011 Apr; 31(4):1399-405. PubMed ID: 21508392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]